Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.

killer immunoglobulin-like receptors monoclonal antibodies natural killer cells polymorphism site-directed mutagenesis

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
08 2022
Historique:
revised: 06 04 2022
received: 12 01 2022
accepted: 08 04 2022
pubmed: 13 4 2022
medline: 20 7 2022
entrez: 12 4 2022
Statut: ppublish

Résumé

Killer immunoglobulin-like receptor (KIR) genes code for a family of inhibitory and activating receptors, finely tuning NK cell function. Numerous studies reported the relevance of KIR allelic polymorphism on KIR expression, ligand affinity, and strength in signal transduction. Although KIR variability, including gene copy number and allelic polymorphism, in combination with HLA class I polymorphism, impacts both KIR expression and NK cell education, only a precise phenotypic analysis can define the size of the different KIR

Identifiants

pubmed: 35411634
doi: 10.1111/tan.14630
pmc: PMC9544867
doi:

Substances chimiques

Antibodies, Monoclonal 0
Epitopes 0
HLA-C Antigens 0
KIR2DL1 protein, human 0
Receptors, KIR 0
Receptors, KIR2DL1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-118

Informations de copyright

© 2022 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd.

Références

Nat Immunol. 2001 May;2(5):452-60
pubmed: 11323700
Front Immunol. 2017 May 26;8:581
pubmed: 28603523
J Immunol. 2010 Jul 1;185(1):433-41
pubmed: 20525888
J Exp Med. 2004 Oct 18;200(8):957-65
pubmed: 15477349
Front Immunol. 2019 May 07;10:909
pubmed: 31134055
Semin Immunol. 2008 Dec;20(6):317-20
pubmed: 18656382
Immunity. 1997 Dec;7(6):739-51
pubmed: 9430220
Immunol Rev. 2001 Jun;181:20-38
pubmed: 11513141
HLA. 2022 Aug;100(2):119-132
pubmed: 35439359
Genome Res. 2012 Oct;22(10):1845-54
pubmed: 22948769
Genes Immun. 2014 Jan;15(1):33-7
pubmed: 24173145
J Immunol. 1998 Jul 15;161(2):571-7
pubmed: 9670929
Nature. 1998 Feb 19;391(6669):795-9
pubmed: 9486650
Tissue Antigens. 2013 Dec;82(6):363-73
pubmed: 24498992
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4778-83
pubmed: 10781084
Blood. 2009 Mar 26;113(13):3119-29
pubmed: 18945967
Immunol Rev. 2015 Sep;267(1):283-97
pubmed: 26284484
BMC Genomics. 2013 Feb 08;14:89
pubmed: 23394822
Front Immunol. 2020 Mar 17;11:440
pubmed: 32256494
Blood. 2007 Jul 1;110(1):433-40
pubmed: 17371948
Trends Immunol. 2018 Jul;39(7):577-590
pubmed: 29793748
Blood. 2008 Sep 15;112(6):2369-80
pubmed: 18583565
Curr Opin Virol. 2016 Feb;16:15-23
pubmed: 26590692
Immunology. 2017 Mar;150(3):248-264
pubmed: 27779741
Annu Rev Immunol. 1996;14:619-48
pubmed: 8717527
Scand J Immunol. 2002 Mar;55(3):221-8
pubmed: 11940227
J Exp Med. 1996 Feb 1;183(2):645-50
pubmed: 8627176
Genes Immun. 2015 Mar;16(2):103-11
pubmed: 25503311
J Immunol. 2007 Nov 1;179(9):5977-89
pubmed: 17947671
J Immunol. 1996 Dec 15;157(12):5367-74
pubmed: 8955184
J Immunol. 2007 Jul 15;179(2):854-68
pubmed: 17617576
Front Immunol. 2020 Mar 12;11:429
pubmed: 32226430
Genes Immun. 2009 Mar;10(2):162-73
pubmed: 19005473
HLA. 2022 Aug;100(2):107-118
pubmed: 35411634
Cell. 2010 Sep 17;142(6):847-56
pubmed: 20850008
J Immunol. 2002 Nov 1;169(9):5118-29
pubmed: 12391228
Immunogenetics. 2017 Aug;69(8-9):567-579
pubmed: 28695291
Front Immunol. 2015 Nov 09;6:573
pubmed: 26617607
Eur J Immunol. 2013 Apr;43(4):1085-98
pubmed: 23436464
Transpl Immunol. 2005 Aug;14(3-4):203-6
pubmed: 15982564
Immunity. 1997 Dec;7(6):753-63
pubmed: 9430221
Eur J Immunol. 1997 Dec;27(12):3095-9
pubmed: 9464792
J Exp Med. 2016 May 2;213(5):791-807
pubmed: 27045007
PLoS Genet. 2015 Aug 20;11(8):e1005439
pubmed: 26292085
Immunity. 2006 Aug;25(2):331-42
pubmed: 16901727
J Clin Invest. 2010 Nov;120(11):4102-10
pubmed: 20972337
Eur J Immunol. 2013 Feb;43(2):480-7
pubmed: 23161492
Cells. 2021 Jul 14;10(7):
pubmed: 34359951
J Immunol. 2013 Sep 1;191(5):2708-16
pubmed: 23918974
Curr Opin Immunol. 2018 Feb;50:102-111
pubmed: 29413815
Front Immunol. 2019 Jun 19;10:1415
pubmed: 31316503
Eur J Immunol. 2014 Jul;44(7):2192-6
pubmed: 24723455
J Immunol. 1990 Apr 15;144(8):3238-47
pubmed: 1691231
J Immunol. 2018 Apr 15;200(8):2640-2655
pubmed: 29549179
Front Immunol. 2012 Nov 22;3:336
pubmed: 23189078
J Immunol. 2001 Mar 1;166(5):2992-3001
pubmed: 11207248
Nat Rev Immunol. 2005 Mar;5(3):201-14
pubmed: 15719024
PLoS One. 2010 Dec 29;5(12):e15115
pubmed: 21206914
Sci Immunol. 2016 Sep;1(3):
pubmed: 27868107
Genome Res. 2009 May;19(5):757-69
pubmed: 19411600
J Immunol. 2015 Oct 1;195(7):3160-70
pubmed: 26311903
Eur J Immunol. 2008 Aug;38(8):2284-9
pubmed: 18624290
Annu Rev Immunol. 2001;19:197-223
pubmed: 11244035
Blood. 2010 Feb 11;115(6):1166-74
pubmed: 19903900
Cancers (Basel). 2020 Apr 11;12(4):
pubmed: 32290478
J Exp Med. 1995 Sep 1;182(3):875-84
pubmed: 7650491
Nat Immunol. 2008 May;9(5):503-10
pubmed: 18425107
Front Immunol. 2021 Jun 21;12:607669
pubmed: 34234770
Blood. 2013 Jun 6;121(23):4703-7
pubmed: 23637128
Cancers (Basel). 2020 Aug 05;12(8):
pubmed: 32764469
J Immunol. 2013 Oct 1;191(7):3553-62
pubmed: 24018270
Annu Rev Immunol. 2013;31:227-58
pubmed: 23516982
Genes Immun. 2015 Jul-Aug;16(5):301-10
pubmed: 25950617

Auteurs

Michela Falco (M)

Laboratory of Clinical and Experimental Immunology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Raffaella Meazza (R)

Laboratory of Immunology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Claudia Alicata (C)

Tumor Immunology Unit, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Paolo Canevali (P)

Laboratory of Immunology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Aura Muntasell (A)

Immunity and Infection laboratory, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Department of Cell Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Cristina Bottino (C)

Laboratory of Clinical and Experimental Immunology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Department of Experimental Medicine, DIMES, University of Genoa, Genoa, Italy.

Lorenzo Moretta (L)

Tumor Immunology Unit, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Daniela Pende (D)

Laboratory of Immunology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Miguel Lopez-Botet (M)

Immunity and Infection laboratory, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH